United States Pharmaceutical Sector Report (2011 Edition)

Synergyst
July 1, 2011
73 Pages - SKU: SYGR6504952
Countries covered: United States

United States is world’s largest spender on healthcare at an estimated 16% of GDP in 2010. This spending is likely to continue to grow at a faster pace in the light of healthcare reforms of 2010 that extended insurance to around 45.7 million residents. United States is the single largest pharmaceutical market globally, accounting for more than 40% of the world's pharmaceutical sales. Over the past two years, however, the U.S. pharmaceutical industry has faced a number of macroeconomic challenges and industry specific issues such as inflation, government healthcare policy, declining levels of innovation, patent losses, among others. The pharmaceutical market in United States is estimated at US$338 billion, growing at 2.5% since 2009 and at a CAGR of 4.5% since 2004. Prescription drugs account for the largest share (88.6%) of total pharmaceutical sales followed by OTC drugs (8.2%) and Alternative Medication (3.2%).

Synergyst’s “United States Pharmaceutical Sector Report (2011 Edition)” is a comprehensive assessment of to the U.S. pharmaceutical market and the trends that are prevailing in the market. Report analyses healthcare, economic and policy environment in the country and presents the SWOT analysis of the country’s pharmaceutical sector. Dynamics of the industry are presented by evaluating the industry structure and estimation of market size, both in terms of volume and dollar value. Market sizing and forecast is provided for the overall market and all the segments from 2005 to 2015. Report also looks at trends that are impacting the pharmaceutical sales in United States and assess the competitive landscape in the industry.



More United States Prescription Drugs reports

Pharmaceuticals and Healthcare Report - United States Q3 2014 by Business Monitor International
United States Pharmaceuticals and Healthcare Report Q3 2014BMI View: The US will remain the most attractive pharmaceutical market in the world for the foreseeablefuture. There ...
Databook Q1 2014: US Social Media Advertising Spend - Pharmaceutical & Healthcare Industry by Socintel360
Databook Q1 2014: US Social Media Advertising Spend in Pharmaceutical & Healthcare IndustrySocial media advertising spend by pharmaceutical & healthcare brands in the US stood ...
Databook Q1 2014: US Digital Advertising Spend - Pharmaceutical & Healthcare Industry by Socintel360
Databook Q1 2014: US Digital Advertising Spend in Pharmaceutical & Healthcare IndustryOnline advertising spend by pharmaceutical & healthcare brands in the US stood at US$1,247 ...
Freedonia Focus on Pharmaceuticals: United States by Freedonia Focus Reports
Freedonia Focus on Pharmaceuticals: United StatesThis report forecasts US pharmaceutical (prescription and over-the-counter) shipments and demand in US dollars at the manufacturers' level to 2018. ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 550  
    Global Site License  USD 900  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!